semaglutide and antipsychotics in Patients With Schizophrenia, Prediabetes, Obesity 🚨 1. Semaglutide significantly improved insulin sensitivity, reduced insulin resistance, lowered fasting glucose, and promoted substantial weight loss in patients with antipsychotic Management of obesity with semaglutide

The [elderly] community is very interested in GLP-1, both from the weight loss perspective, but also [when it comes to] the reduction of inflammation, which also seems to drive part of aging

Meals feel satisfying again instead of turning into a cycle of overeating and guilt afterward

Misra, D

DHmeds.com | Dr Hirsch Home Weight Loss, LLC 1250 S Tamiami Trail, Sarasota, Florida 34239, United States 941-365-2122 Copyright 2024 Dr Hirsch Home Weight Loss, LLC | DHmeds.com - All Rights Reserved

Meet the weight-management clinical criteria (measured at the time GLP-1 therapy was first started): BMI of 35 or higher, or BMI of 30 or higher with heart failure (preserved ejection fraction), uncontrolled high blood pressure, or chronic kidney disease (stage 3a or above), or BMI of 27 or higher with prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease

Anti-Aging Besides creating healthier and lighter skin, Flawless Skin Capsules also plays as an anti-aging agent